Claudia Andl
Faculty Member
Last active: 10/13/2015


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Urinary oncofetal ED-A fibronectin correlates with poor prognosis in patients with bladder cancer. Arnold SA, Loomans HA, Ketova T, Andl CD, Clark PE, Zijlstra A (2016) Clin Exp Metastasis 33(1): 29-44
    › Primary publication · 26456754 (PubMed) · PMC4742427 (PubMed Central)
  2. Activin a signaling regulates cell invasion and proliferation in esophageal adenocarcinoma. Taylor C, Loomans HA, Le Bras GF, Koumangoye RB, Romero-Morales AI, Quast LL, Zaika AI, El-Rifai W, Andl T, Andl CD (2015) Oncotarget 6(33): 34228-44
    › Primary publication · 26447543 (PubMed) · PMC4741448 (PubMed Central)
  3. Targeting HCC Therapy: On or Off ToPiX? Andl CD (2015) Dig Dis Sci 60(8): 2219-21
    › Primary publication · 26062821 (PubMed) · PMC4518732 (PubMed Central)
  4. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells. Koumangoye RB, Andl T, Taubenslag KJ, Zilberman ST, Taylor CJ, Loomans HA, Andl CD (2015) Mol Cancer : 24
    › Primary publication · 25644061 (PubMed) · PMC4374188 (PubMed Central)
  5. Helicobacter pylori bacteria alter the p53 stress response via ERK-HDM2 pathway. Bhardwaj V, Noto JM, Wei J, Andl C, El-Rifai W, Peek RM, Zaika AI (2015) Oncotarget 6(3): 1531-43
    › Primary publication · 25605238 (PubMed) · PMC4359312 (PubMed Central)
  6. Intertwining of Activin A and TGFβ Signaling: Dual Roles in Cancer Progression and Cancer Cell Invasion. Loomans HA, Andl CD (2014) Cancers (Basel) 7(1): 70-91
    › Primary publication · 25560921 (PubMed) · PMC4381251 (PubMed Central)
  7. Concerted loss of TGFβ-mediated proliferation control and E-cadherin disrupts epithelial homeostasis and causes oral squamous cell carcinoma. Andl T, Le Bras GF, Richards NF, Allison GL, Loomans HA, Washington MK, Revetta F, Lee RK, Taylor C, Moses HL, Andl CD (2014) Carcinogenesis 35(11): 2602-10
    › Primary publication · 25233932 (PubMed) · PMC4216061 (PubMed Central)
  8. Activin A balance regulates epithelial invasiveness and tumorigenesis. Le Bras GF, Loomans HA, Taylor CJ, Revetta FL, Andl CD (2014) Lab Invest 94(10): 1134-46
    › Primary publication · 25068654 (PubMed) · PMC4309391 (PubMed Central)
  9. TGFβ loss activates ADAMTS-1-mediated EGF-dependent invasion in a model of esophageal cell invasion. Le Bras GF, Taylor C, Koumangoye RB, Revetta F, Loomans HA, Andl CD (2015) Exp Cell Res 330(1): 29-42
    › Primary publication · 25064463 (PubMed) · PMC4267897 (PubMed Central)
  10. Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes. Kadaba R, Birke H, Wang J, Hooper S, Andl CD, Di Maggio F, Soylu E, Ghallab M, Bor D, Froeling FE, Bhattacharya S, Rustgi AK, Sahai E, Chelala C, Sasieni P, Kocher HM (2013) J Pathol 230(1): 107-17
    › Primary publication · 23359139 (PubMed) · PMC4034674 (PubMed Central)
  11. The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progression. Le Bras GF, Taubenslag KJ, Andl CD (2012) Cell Adh Migr 6(4): 365-73
    › Primary publication · 22796940 (PubMed) · PMC3478259 (PubMed Central)
  12. CD44 upregulation in E-cadherin-negative esophageal cancers results in cell invasion. Le Bras GF, Allison GL, Richards NF, Ansari SS, Washington MK, Andl CD (2011) PLoS One 6(11): e27063
    › Primary publication · 22069487 (PubMed) · PMC3206075 (PubMed Central)
  13. p73 protein regulates DNA damage repair. Zaika E, Wei J, Yin D, Andl C, Moll U, El-Rifai W, Zaika AI (2011) FASEB J 25(12): 4406-14
    › Primary publication · 21891782 (PubMed) · PMC3236618 (PubMed Central)
  14. Cell adhesion signaling and its impact on tumorigenesis. Andl CD, Al Moustafa AE, Deramaudt TB, O'Neill GM (2010) J Oncol : 257809
    › Primary publication · 21274443 (PubMed) · PMC3025370 (PubMed Central)
  15. The Misregulation of Cell Adhesion Components during Tumorigenesis: Overview and Commentary. Andl CD (2010) J Oncol
    › Primary publication · 20953359 (PubMed) · PMC2952821 (PubMed Central)
  16. Cathepsin B is the driving force of esophageal cell invasion in a fibroblast-dependent manner. Andl CD, McCowan KM, Allison GL, Rustgi AK (2010) Neoplasia 12(6): 485-98
    › Primary publication · 20563251 (PubMed) · PMC2887089 (PubMed Central)
  17. The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation. Okawa T, Michaylira CZ, Kalabis J, Stairs DB, Nakagawa H, Andl CD, Johnstone CN, Klein-Szanto AJ, El-Deiry WS, Cukierman E, Herlyn M, Rustgi AK (2007) Genes Dev 21(21): 2788-803
    › Primary publication · 17974918 (PubMed) · PMC2045132 (PubMed Central)
  18. IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms. Takaoka M, Kim SH, Okawa T, Michaylira CZ, Stairs DB, Johnstone CN, Andl CD, Rhoades B, Lee JJ, Klein-Szanto AJ, El-Deiry WS, Nakagawa H (2007) Cancer Biol Ther 6(4): 534-40
    › Primary publication · 17457048 (PubMed) · PMC2993006 (PubMed Central)
  19. Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells. Lioni M, Brafford P, Andl C, Rustgi A, El-Deiry W, Herlyn M, Smalley KS (2007) Am J Pathol 170(2): 709-21
    › Primary publication · 17255337 (PubMed) · PMC1851859 (PubMed Central)
  20. Coordinated functions of E-cadherin and transforming growth factor beta receptor II in vitro and in vivo. Andl CD, Fargnoli BB, Okawa T, Bowser M, Takaoka M, Nakagawa H, Klein-Szanto A, Hua X, Herlyn M, Rustgi AK (2006) Cancer Res 66(20): 9878-85
    › Primary publication · 17047049 (PubMed) · PMC2996096 (PubMed Central)